ADC Therapeutics SA
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | |
| – | +117.0% | +122.4% | +32.9% | +20.2% | -11.5% | +40.3% | +0.3% | -42.7% | |
| – | -52.1% | +138.2% | +3,264.8% | +60.9% | -18.4% | -72.6% | -51.3% | +5.1% | |
| – | -118.6% | – | +6,548.5% | -77.4% | +247.5% | – | – | – | |
| – | -96.4% | -1,738.9% | – | -227.1% | – | – | -91.4% | -762.7% | |
| – | -21.7% | -13.0% | +30.8% | +127.0% | -91.0% | +457.4% | -73.0% | -69.6% | |
| – | -22.8% | -10.3% | +25.8% | +136.0% | -62.4% | +28.2% | -73.0% | – | |
| – | -100.0% | +487.5% | -100.0% | – | – | – | – | – | |
| – | +0.0% | +0.0% | – | -21.3% | -113.4% | -100.0% | – | – | |
| – | -100.0% | – | +392.4% | -46.0% | -100.2% | – | +31.4% | +55.5% | |
| – | -204.1% | – | – | -91.5% | -611.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.